News

Census Launch: India’s first phase of Census 2026 starts April 1 with houselisting, followed by population enumeration in 2027.
In this article, a single-phase transformerless inverter for photovoltaic (PV) applications is introduced. The proposed inverter provides common ground between input and output terminals, which ...
DC offset in the input of phase-locked loops (PLLs) is a challenging problem since it will result in fundamental frequency oscillations in the estimated phase and frequency. In this paper, a ...
Eyestem has announced the completion of its phase 1 study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The company has submitted the results to the Central Drugs ...
Placebo-subtracted mean weight loss up to 8.4% at Day 36 19-day observed half-life supports once-monthly dosing as monotherapy and potential first-in-category monthly GLP-1 + Amylin combination ...
The 8.4% weight loss mark reported Monday was achieved by the 1.2 mg dose, the highest of four doses of the drug administered weekly for five weeks in a two-part Phase 1 study. Each part enrolled ...
Dr Alex Boote, product and innovation manager at ARC Building Solutions, a manufacturer of cavity fire barriers and insulation products The government recently announced its plan for Phase 1 of ...
The 2025 MLB All-Star Game in Atlanta will have a Motor City feel if the voting trends continue. But voting hasn't ended. It has only transitioned from Phase 1 to Phase 2, with Báez, Greene and ...
The randomised, phase 1 study will evaluate the safety, tolerability, and immunogenicity of the nucleoside-modified RNA (modRNA)based combination vaccine, which combines Pfizer’s quadrivalent ...
Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.
Innovent Biologics presents data from phase 1 PoC study of IBI363 to treat advanced NSCLC at 2025 ASCO San Francisco Friday, June 6, 2025, 18:00 Hrs [IST] Innovent Biologics, Inc. (Innovent), a ...
As Kanu’s trial reaches a “crucial and decisive phase,” IPOB urged all stakeholders to remain “vigilant, vocal, and committed,” adding that the leader’s spirit remains unbroken and ...